Skip to content

Author

R. Omer

We have 12 of 152 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Emerging analytical techniques for tamoxifen and metabolite quantification in diverse matrices.

Tamoxifen (TMX), a key selective estrogen receptor (ER) modulator used in hormone-dependent breast cancer therapy, undergoes extensive metabolism to produce active metabolites, including endoxifen (END), 4-hydroxytamoxifen (4HT), and N-desmethyltamoxifen (NDT). The simultaneous determination of these compounds across p...

H. Barzani, R. Omer, N. Abdulrahman et al. · 0 citations
Open access Sep 2026

Health Risk Assessment Associated with Diesel Induced SO₂ Emissions in Erbil City: A Box Model Estimation.

Diesel with high sulfur content is a major contributor to sulfur dioxide (SO₂) emissions in urban environments, posing health risks to populations residing near high-traffic roads. This study investigated the influence of diesel sulfur content on SO₂ exposure and the associated non-carcinogenic health risks in resident...

Shaymaa H. Ahmed, S. Ahmed, R. Omer · 0 citations
Review Sep 2026

Comprehensive evaluation of analytical methods for determination of ansamycins across diverse matrices.

Ansamycins (ANs), including rifampicin (RIF), rifabutin (RFB), rifapentine (RPT), rifalazil (RFL), and rifaximin (RFX), are structurally distinctive macrocyclic antibiotics whose analytical determination is complicated by very low systemic exposure (especially RFX), high protein binding and intracellular sequestration...

H. Barzani, R. Omer, A. H. Mer et al. · 0 citations
Review Open access Aug 2026

Sucralose and Human Health: Metabolic, Microbiome, Neuroendocrine, Toxicological, and Environmental Perspectives

Sucralose is a prevalent non-nutritive sweetener characterised by its chemical stability, intense sweetness, and low-calorie content, which have facilitated its global acceptance, regulatory endorsement, and an acceptable daily intake (ADI) of 5 mg/kg. However, recent data question its presumed inertness and undersco...

A. Qadir, R. Omer · 0 citations
Review Sep 2026

Analytical determination of meloxicam and tenoxicam: matrix-dependent challenges, emerging technologies, and sustainable future perspectives.

Future progress should shift from isolated improvements in detection sensitivity toward matrix-adaptive, digitally assisted, sustainability-aware analytical systems that integrate automated sample preparation, intelligent data interpretation, robust validation, and lifecycle-based performance assessment.

H. Barzani, R. Omer, Sarbast Naser Ahmed et al. · 0 citations
Review Open access Aug 2026

Saccharin Revisited: Chemistry, Metabolism, Toxicology and Human Health Risk Assessment in the Era of Evidence-Based Food Safety.

A comprehensive and critical synthesis of current knowledge on saccharin, encompassing its chemical characteristics, physicochemical properties, industrial and pharmaceutical applications, absorption, metabolism, excretion and toxicological profile is provided.

A. Qadir, A. Ahmed, Musa M. Zorab et al. · 0 citations
Review Sep 2026

Dyslipidaemia: Pathophysiology, Epidemiology, Diagnostic Advances, and Emerging Therapeutic Strategies

This review elucidates the complex pathophysiology, epidemiological dynamics, and genetic architectures defining dyslipidaemia, delineating primary hereditary molecular defects from secondary acquired etiologies and discusses persistent barriers to patient adherence and the transformative potential of precision medicin...

A. Qadir, R. Omer, H. Barzani et al. · 0 citations
#explainable ai Review Sep 2026

AI-assisted sustainable pharmaceutical bioanalysis: critical review of LC-MS, matrix effects, and white analytical chemistry.

This critical review comprehensively evaluates the current state of pharmaceutical bioanalysis by examining emerging LC-MS technologies, sustainable analytical strategies, and the growing role of artificial intelligence (AI) and machine learning (ML) in analytical optimization, spectral interpretation, biomarker discov...

H. Barzani, R. Omer, Khalamala Ibrahim Salih Barzani et al. · 0 citations
Aug 2026

In silico evaluation of novel metabolites from Tricholoma pardinum: Insights into drug-likeness, toxicity and target interactions via molecular docking and dynamics.

Six previously uncharacterized metabolites isolated from the poisonous mushroom Tricholoma pardinum are investigated using an integrated in silico approach to evaluate their therapeutic potential, highlighting the potential of metabolites from T. pardinum as novel scaffolds for developing anticancer agents targeting PA...

A. Amin, H. M. Amin, A. R. Hamad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.